Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis

This study has been completed.
Information provided by:
Bayer Identifier:
First received: September 9, 2005
Last updated: November 21, 2012
Last verified: November 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2005
  Estimated Primary Completion Date: No date given